Xcout Intel
Artax Biopharma, Inc.
Artax Biopharma, Inc. is a clinical-stage biotechnology company founded in 2013 and headquartered in Cambridge, Massachusetts. The company is focused on transforming the treatment of immune system diseases and recently raised $8 million ahead of a Phase 2a clinical trial.
Subscribe to see Artax Biopharma, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Artax Biopharma, Inc. at a glance
Artax Biopharma, Inc. is a biotechnology company headquartered in United States. Its most recent funding round raised $8M in July 2024. Xcout tracks 16 named people at Artax Biopharma, Inc., including Rob Armstrong (Chief Executive Officer).
Artax Biopharma, Inc. leadership
- Rob ArmstrongChief Executive Officer
- Robert Armstrong, Ph.D.President & Chief Executive Officer
- Andy GageteChief Operating Officer
- Joe SuarezChief Financial Officer
- Chris VanDeusenChief Scientific Officer
- D. Scott Batty, Jr.Chief Medical Officer
10 more named people on record for Artax Biopharma, Inc., with roles, board committees and tenure — see the full roster →
Artax Biopharma, Inc. funding rounds
The 4 most recent:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $8M | 7 named | |
| — | $19M | 7 named | |
| — | Undisclosed | 6 named | |
| SEC Form D filing | $25.8M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Artax Biopharma, Inc. competitors
A few of Artax Biopharma, Inc.'s closest competitors — see the full list of competitors and alternatives →
Ankyra Therapeutics, Inc. is a clinical-stage biotechnology company founded in 2019 and headquartered in Cambridge, Massachusetts. The enterprise specializes in developing proprietary anchored cytokine therapies designed to treat various cancers and immune diseases. Its platform technology localizes immune-stimulatory treatments within tumors to maximize therapeutic efficacy while minimizing systemic toxicity.
Apogee Therapeutics is a biotechnology company focused on the development of therapies for inflammatory and immunology diseases. The company is headquartered in Waltham, Massachusetts.
Artiva Biotherapeutics, Inc. is a clinical-stage biotechnology firm specializing in the development of natural killer (NK) cell-based treatments for individuals afflicted with autoimmune disorders and various forms of cancer. Its flagship therapeutic candidate, AB-101, is an innovative, ready-to-use (off-the-shelf) NK cell therapy. This treatment is being developed for a broad spectrum of conditions, including autoimmune diseases like lupus nephritis, rheumatoid arthritis, pemphigus vulgaris, systemic lupus erythematosus, and specific anti-neutrophil cytoplasmic antibody-associated vasculitis subtypes such as granulomatosis with polyangiitis/microscopic polyangiitis, in addition to B-cell non-Hodgkin lymphoma. The company's pipeline also includes AB-201, an allogeneic anti-human epidermal growth factor receptor 2 chimeric antigen receptor (CAR)-NK cell candidate, and AB-205, another allogeneic anti-CD5 CAR-NK cell candidate. Established in 2019, Artiva Biotherapeutics is headquartered in San Diego, California.
Immunitas Therapeutics, Inc. is a US-based biotechnology company established in 2019 and headquartered in Waltham, Massachusetts. The company focuses on pioneering novel therapeutic treatments in immunology and oncology.
HiFiBio Therapeutics is a clinical-stage immune modulation biotechnology company headquartered in Cambridge, Massachusetts. The company focuses on discovering and developing novel precision antibody therapeutics for immunology and oncology applications.
Get Artax Biopharma, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Artax Biopharma, Inc. in Xcout Intel
- 16 named people with titles, LinkedIn and board committees
- 10 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access